Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the treatment menu has been frustratingly short: a modest pill called ezetimibe ...
Morning Overview on MSN
A single gene-silencing shot just cut dangerous cholesterol in half for a full year — built to replace the daily statins millions of adults already take
Roughly 40 million adults in the United States take a statin pill every day to keep their cholesterol in check, according to ...
Statins are known to be associated with increased insulin resistance and higher blood glucose levels, but now a new observational study demonstrates that these metabolic changes translate into ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. It’s a math problem with ...
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Far fewer people who could ...
Statin use is linked to better survival in breast cancer, observational data from Taiwan suggest. Yet researchers only saw a difference for all-cause and cancer-related deaths, not CV death. The ...
Far fewer people who could benefit from statins actually take the cholesterol-lowering drugs now. Many who start taking them stop. The long list of side effects, detailed in fine print on package ...
EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...
The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...
HKUMed demonstrates that statins can lower the risk of cardiovascular disease without increasing major adverse events, providing guidance for future clinical practice in managing high cholesterol. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results